Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.04%
#2 Pons Pons +38.47%
#3 Starpower Starpower +30.38%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.10%
#5 TENDIES TENDIES +24.03%
#6 Mubarak Mubarak +23.85%
#7 StonkBroker StonkBroker +21.99%
#8 SkyAI SkyAI +20.90%
#9 Decred Decred +19.75%
#10 PondCoin PondCoin +17.74%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
PT Indofarma Tbk PT Indofarma Tbk

PT Indofarma Tbk

INAF
Classifica tra le azioni #29054
PT Indofarma Tbk, along with its affiliated entities, is dedicated to the... PT Indofarma Tbk, along with its affiliated entities, is dedicated to the production and marketing of pharmaceutical goods across Indonesia. The company's activities encompass the commerce and supply of a diverse range of items, including medications, medical equipment, healthcare provisions, various extracts, and herbal products. It also operates its own laboratory facilities and provides specific COVID-19 diagnostic services, such as rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), and Genose tests. Additionally, the firm engages in the export of its merchandise. Established in 1918, Indofarma Tbk maintains its primary operations in Bekasi, Indonesia. Historically, the company was known as PT Indofarma (Persero) Tbk and now functions as a subsidiary of PT. Bio Farma.
Prezzo delle azioni
$0.00748841
Ultima sincronizzazione: 2024-07-01
Capitalizzazione di mercato
$23.21M
Variazione (1 giorno)
-2.83%
Variazione (1 anno)
0.00%
Paese
ID
Scambia PT Indofarma Tbk (INAF)

Categoria

Healthcare
Ricavi di PT Indofarma Tbk (INAF)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di PT Indofarma Tbk, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per PT Indofarma Tbk da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN